Livedo reticularis - I-Livedo Reticularis
https://en.wikipedia.org
/wiki/Livedo_reticularis
I-
I-Livedo Reticularis (Livedo reticularis)
iwukutholakala kwesikhumba okuvamile okuhlanganisa iphethini yemithambo enemagqabhagqabha ebonakala njengokuguquguquka okunsomi okufana neleyisi kwesikhumba. Kungase kubhebhethekiswe ukuchayeka emakhazeni, futhi kwenzeka kaningi ezindaweni eziphansi. Ukushintsha kombala kubangelwa ukuncipha kokugeleza kwegazi kuma-arterioles ahlinzeka ngama-capillaries e-cutaneous, okuholela egazini elingenawo umoya-mpilo obonakala njengombala oluhlaza okwesibhakabhaka. Lokhu kungase kubangelwe okwesibili yi-hyperlipidemia, i-microvascular hematological noma i-anemia, ukuntula ukudla okunomsoco, izifo ze-hyper- kanye ne-autoimmune, kanye nezidakamizwa/ubuthi.
Ulwazi olwengeziwe ― Zulu
Livedo reticularis is a common skin finding consisting of a mottled reticulated vascular pattern that appears as a lace-like purplish discoloration of the skin.
☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
Isilonda ngenxa ye-infrarenal aortoiliac stenosis enzima.
Erythema ab igne vs. Livedo reticularis
Ukusesha isithombe
relevance score : -100.0%
References
Livedo reticularis: A review of the literature
26500860
NIH
I- Livedo reticularis (LR) yisimo sesikhumba esimakwa yiphethini yesikhashana noma ehlala njalo, enamagqabhagqabha, ebomvu-eluhlaza okwesibhakabhaka ukuya kokunsomi, efana nenethi. Ihlasela kakhulu abesifazane abaneminyaka ephakathi futhi ngokuvamile ayinazimpawu. Ngakolunye uhlangothi, i- livedo racemosa (LRC) iwuhlobo olubucayi kakhulu oluvame ukuxhunyaniswa ne-antiphospholipid antibody syndrome.
Livedo reticularis (LR) is a cutaneous physical sign characterized by transient or persistent, blotchy, reddish-blue to purple, net-like cyanotic pattern. LR is a benign disorder affecting mainly middle-aged females, whereas livedo racemosa (LRC) is pathologic, commonly associated with antiphospholipid antibody syndrome.